Table 2.
Formulation | Diameter (nm) | Zeta potential (mV) | Drug:Lipid (mg:mg) |
---|---|---|---|
NTSL | 129.7 ± 8.7 | −12.0 ± 1.3 | 0.0633 ± 0.005 |
TSL | 131.7 ± 13.3 | −13.8 ± 5.1 | 0.0669 ± 0.012 |
PTSL | 122.2 ± 1.1 | −6.5 ± 2.9 | 0.0649 ± 0.018 |
Formulation | Diameter (nm) | Zeta potential (mV) | Drug:Lipid (mg:mg) |
---|---|---|---|
NTSL | 129.7 ± 8.7 | −12.0 ± 1.3 | 0.0633 ± 0.005 |
TSL | 131.7 ± 13.3 | −13.8 ± 5.1 | 0.0669 ± 0.012 |
PTSL | 122.2 ± 1.1 | −6.5 ± 2.9 | 0.0649 ± 0.018 |